213 related articles for article (PubMed ID: 18405174)
1. Vasculopathy and vasculitis in systemic lupus erythematosus.
Cieślik P; Hrycek A; Kłuciński P
Pol Arch Med Wewn; 2008; 118(1-2):57-63. PubMed ID: 18405174
[TBL] [Abstract][Full Text] [Related]
2. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner.
Carvalho D; Savage CO; Isenberg D; Pearson JD
Arthritis Rheum; 1999 Apr; 42(4):631-40. PubMed ID: 10211876
[TBL] [Abstract][Full Text] [Related]
3. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis.
D'Cruz DP; Houssiau FA; Ramirez G; Baguley E; McCutcheon J; Vianna J; Haga HJ; Swana GT; Khamashta MA; Taylor JC
Clin Exp Immunol; 1991 Aug; 85(2):254-61. PubMed ID: 1864005
[TBL] [Abstract][Full Text] [Related]
5. Anti-endothelial cell antibodies in patients with systemic lupus erythematosus.
Liu MF; Lei HY
J Formos Med Assoc; 1991 Mar; 90(3):221-4. PubMed ID: 1677395
[TBL] [Abstract][Full Text] [Related]
6. [The role of endothelial cells in the pathogenesis of systemic lupus erythematosus].
Robak E; Kierstan MK; Kulczycka L; Sysa-Jedrzejowska A
Postepy Hig Med Dosw (Online); 2007 Jun; 61():413-9. PubMed ID: 17572660
[TBL] [Abstract][Full Text] [Related]
7. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
Cieślik P; Hrycek A
Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
[TBL] [Abstract][Full Text] [Related]
8. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
[TBL] [Abstract][Full Text] [Related]
9. The impact of anti-endothelial cell antibodies (AECAs) on the development of blood vessel damage in patients with systemic lupus erythematosus: the preliminary study.
Cieślik P; Semik-Grabarczyk E; Hrycek A; Holecki M
Rheumatol Int; 2022 May; 42(5):791-801. PubMed ID: 35284968
[TBL] [Abstract][Full Text] [Related]
10. Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus.
Song J; Park YB; Lee WK; Lee KH; Lee SK
Rheumatol Int; 2000 Dec; 20(1):1-7. PubMed ID: 11149654
[TBL] [Abstract][Full Text] [Related]
11. Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance.
Navarro M; Cervera R; Font J; Reverter JC; Monteagudo J; Escolar G; López-Soto A; Ordinas A; Ingelmo M
Lupus; 1997; 6(6):521-6. PubMed ID: 9256310
[TBL] [Abstract][Full Text] [Related]
12. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.
Yoshio T; Masuyama J; Sumiya M; Minota S; Kano S
J Rheumatol; 1994 Nov; 21(11):2058-63. PubMed ID: 7869310
[TBL] [Abstract][Full Text] [Related]
13. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
Narshi CB; Giles IP; Rahman A
Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies in systemic lupus erythematosus and urticarial vasculitis.
D'Cruz DP; Wisnieski JJ; Asherson RA; Khamashta MA; Hughes GR
J Rheumatol; 1995 Sep; 22(9):1669-73. PubMed ID: 8523343
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis.
Del Papa N; Conforti G; Gambini D; La Rosa L; Tincani A; D'Cruz D; Khamashta M; Hughes GR; Balestrieri G; Meroni PL
Clin Immunol Immunopathol; 1994 Mar; 70(3):211-6. PubMed ID: 8313658
[TBL] [Abstract][Full Text] [Related]
16. Characterization of anti-endothelial cell antibodies in the patients with systemic lupus erythematosus: a potential marker for disease activity.
Li JS; Liu MF; Lei HY
Clin Immunol Immunopathol; 1996 Jun; 79(3):211-6. PubMed ID: 8635277
[TBL] [Abstract][Full Text] [Related]
17. Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro.
Del Papa N; Raschi E; Moroni G; Panzeri P; Borghi MO; Ponticelli C; Tincani A; Balestrieri G; Meroni PL
Lupus; 1999; 8(6):423-9. PubMed ID: 10483009
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis.
Praprotnik S; Rozman B; Blank M; Shoenfeld Y
Wien Klin Wochenschr; 2000 Aug; 112(15-16):660-4. PubMed ID: 11020952
[TBL] [Abstract][Full Text] [Related]
19. Anti-endothelial cell antibodies in systemic vasculitis and systemic lupus erythematosus (SLE): effects of heat inactivation on binding and specificity.
D'Cruz DP; Keser G; Direskeneli H; Khamashta MA; Hughes GR
Clin Exp Immunol; 1999 Mar; 115(3):567-70. PubMed ID: 10193435
[TBL] [Abstract][Full Text] [Related]
20. Induction of endothelial cell apoptosis by IgG antibodies from SLE patients with nephropathy: a potential role for anti-endothelial cell antibodies.
van Paassen P; Duijvestijn A; Debrus-Palmans L; Damoiseaux J; Vroomen M; Tervaert JW
Ann N Y Acad Sci; 2007 Jun; 1108():147-56. PubMed ID: 17893981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
